Literature DB >> 8021970

Isoforms of ferritin have a specific cellular distribution in the brain.

J R Connor1, K L Boeshore, S A Benkovic, S L Menzies.   

Abstract

Ferritin is the major iron storage protein and accounts for the majority of the iron in the brain. Thus, ferritin is a key component in protecting the brain from iron induced oxidative damage. The high lipid content, high rate of oxidative metabolism, and high iron content combine to make the brain the organ most susceptible to oxidative stress. The role of oxidative damage and disruption of brain iron homeostasis is considered clinically important to normal aging and a potential pathogenic component of a number of neurologic disorders including Alzheimer's disease and Parkinson's disease. Little is known, however, of the mechanism by which the brain maintains iron homeostasis at either the whole organ or cellular level. In this study we report the cellular distribution of the two isoforms of ferritin in the brain of adult subhuman primates. A subset of neurons immunolabel specifically for the H-chain ferritin protein, whereas cells resembling microglia are immunolabeled only after exposure to the L-chain ferritin antibody. Only one cell type immunostains for both H- and L-chain ferritin; these cells are morphologically similar and have the same distribution pattern as oligodendrocytes. Neither ferritin isoform is usually detected in astrocytes. These data indicate considerable differences in iron sequestration and use between neurons and glia and among neuronal and glial subtypes. This information will be essential in determining the role of each of these cells in maintaining general brain iron homeostasis and the relative abilities of these cells to withstand oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021970     DOI: 10.1002/jnr.490370405

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  37 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury.

Authors:  Jin-Yul Lee; Richard F Keep; Yangdong He; Oren Sagher; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

3.  Neuroscience in Africa.

Authors:  Susan J van Rensburg; Brian Harvey
Journal:  Metab Brain Dis       Date:  2006-09       Impact factor: 3.584

Review 4.  Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus.

Authors:  M B H Youdim
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

5.  Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro.

Authors:  Erin K Stachowski; Robert Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2011-08-11       Impact factor: 3.575

Review 6.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

7.  Microglia activation is related to substantia nigra echogenicity.

Authors:  D Berg; J Godau; P Riederer; M Gerlach; T Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

8.  Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children.

Authors:  Elizabeth Newell; David K Shellington; Dennis W Simon; Michael J Bell; Patrick M Kochanek; Keri Feldman; Hülya Bayir; Rajesh K Aneja; Joseph A Carcillo; Robert S B Clark
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

9.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.

Authors:  David L Schonberg; Tyler E Miller; Qiulian Wu; William A Flavahan; Nupur K Das; James S Hale; Christopher G Hubert; Stephen C Mack; Awad M Jarrar; Robert T Karl; Ann Mari Rosager; Anne M Nixon; Paul J Tesar; Petra Hamerlik; Bjarne W Kristensen; Craig Horbinski; James R Connor; Paul L Fox; Justin D Lathia; Jeremy N Rich
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

10.  Assessment of Iron Deposition in the Brain in Frontotemporal Dementia and Its Correlation with Behavioral Traits.

Authors:  R Sheelakumari; C Kesavadas; T Varghese; R M Sreedharan; B Thomas; J Verghese; P S Mathuranath
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-24       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.